GB0325598D0 - Compound and use in treatment - Google Patents
Compound and use in treatmentInfo
- Publication number
- GB0325598D0 GB0325598D0 GBGB0325598.1A GB0325598A GB0325598D0 GB 0325598 D0 GB0325598 D0 GB 0325598D0 GB 0325598 A GB0325598 A GB 0325598A GB 0325598 D0 GB0325598 D0 GB 0325598D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compound
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (29)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0325598A GB2407499B (en) | 2003-11-03 | 2003-11-03 | Vitamin D3 analogue for use in the treatment of BPH |
CA002476224A CA2476224A1 (en) | 2003-09-24 | 2004-07-29 | Compound and use in treatment |
PT103177A PT103177A (en) | 2003-09-24 | 2004-07-29 | 1-ALPHA-FLUORO-25-HYDROXY-16,23E-DIENE-26,27-BIS-HOMO-20-EPI-COLECALCIFEROL, ITS SALTS OR ESTERS AND ITS USE IN THE MANUFACTURE OF MEDICINES |
SG200404316A SG110107A1 (en) | 2003-09-24 | 2004-07-29 | Compound and use in treatment |
AU2004203436A AU2004203436A1 (en) | 2003-09-24 | 2004-07-29 | Compound and use in treatment |
US10/903,211 US7332482B2 (en) | 2003-09-24 | 2004-07-29 | Method for treating benign prostatic hyperplasia |
CH01553/04A CH698144B1 (en) | 2003-09-24 | 2004-09-22 | Analogue of vitamin D3 |
BR0404050-3A BRPI0404050A (en) | 2003-09-24 | 2004-09-22 | Use of a compound or pharmaceutically acceptable salt or ester thereof, pharmaceutical formulation, packaged formulation, compound, and method for preventing and / or treating benign prostate hyperplasia in patients in need of such prevention or treatment. |
NZ535531A NZ535531A (en) | 2003-09-24 | 2004-09-23 | Compound and use in treatment |
FR0410073A FR2859910B1 (en) | 2003-09-24 | 2004-09-23 | USE OF 1-ALPHA-FLUORO-25-HYDROXY-16,23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA |
EA200401100A EA010240B1 (en) | 2003-09-24 | 2004-09-23 | 1-alpha-fluoro-25-hydroxy-16,23e-diene-26,27-bishomo-20-epicholecalciferol and use for treatment thereof |
EP04765598A EP1673096A1 (en) | 2003-09-24 | 2004-09-24 | Use of a vitamin d3 analogue for the treatment of benign prostatic hyperplasia |
CNB2004100800817A CN100488511C (en) | 2003-09-24 | 2004-09-24 | Compound and use for preparation of the medicament for treatment of benign prostatic hyperplasia and relative diseases |
US10/573,164 US20070054887A1 (en) | 2003-09-24 | 2004-09-24 | Methods for treating bladder dysfunction |
JP2006528270A JP2007506780A (en) | 2003-09-24 | 2004-09-24 | Method for treating bladder dysfunction |
JP2006527365A JP2007506699A (en) | 2003-09-24 | 2004-09-24 | Use of vitamin D3 analogs for the treatment of benign prostatic hyperplasia |
AU2004275845A AU2004275845A1 (en) | 2003-09-24 | 2004-09-24 | Methods for treating bladder dysfunction |
BRPI0414701-4A BRPI0414701A (en) | 2003-09-24 | 2004-09-24 | use of a vitamin d compound, method of prevention or treatment of bladder dysfunction in a patient, vitamin d compound e, kit |
NL1027109A NL1027109C2 (en) | 2003-09-24 | 2004-09-24 | Connection and use with treatment. |
PCT/US2004/031532 WO2005030223A1 (en) | 2003-09-24 | 2004-09-24 | Methods for treating bladder dysfunction |
CA002540325A CA2540325A1 (en) | 2003-09-24 | 2004-09-24 | Methods for treating bladder dysfunction |
BE2004/0472A BE1016292A3 (en) | 2003-09-24 | 2004-09-24 | CONNECTION AND USE IN TREATMENT. |
EP04789064A EP1663250A4 (en) | 2003-09-24 | 2004-09-24 | Methods for treating bladder dysfunction |
PCT/EP2004/010760 WO2005027923A1 (en) | 2003-09-24 | 2004-09-24 | Use of vitamin d3 analogue for the treatment of benign prostatic hyperplasia |
HK05108113.0A HK1085373A1 (en) | 2003-09-24 | 2005-09-16 | Compound and use in the manufacture of a medicament for the treatment of benign prostatic hyperplasia and associated symptoms |
IL174369A IL174369A0 (en) | 2003-09-24 | 2006-03-16 | Methods for treating bladder dysfunction |
US11/977,502 US20080207769A1 (en) | 2003-09-24 | 2007-10-24 | Method for treating benign prostatic hyperplasia |
AU2008203397A AU2008203397A1 (en) | 2003-09-24 | 2008-07-30 | Compound and use in treatment |
JP2008209429A JP2009035559A (en) | 2003-09-24 | 2008-08-18 | Use of vitamin d3 analog for the treatment of benign prostatic hyperplasia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0325598A GB2407499B (en) | 2003-11-03 | 2003-11-03 | Vitamin D3 analogue for use in the treatment of BPH |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0325598D0 true GB0325598D0 (en) | 2003-12-10 |
GB2407499A GB2407499A (en) | 2005-05-04 |
GB2407499B GB2407499B (en) | 2008-02-27 |
Family
ID=29725834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0325598A Expired - Fee Related GB2407499B (en) | 2003-09-24 | 2003-11-03 | Vitamin D3 analogue for use in the treatment of BPH |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2407499B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW403735B (en) * | 1995-11-22 | 2000-09-01 | Hoffmann La Roche | 25-hydroxy-16-ene-26, 27-bishomo-cholecalciferol |
SG70009A1 (en) * | 1996-05-23 | 2000-01-25 | Hoffmann La Roche | Vitamin d3 analogs |
US6331642B1 (en) * | 1999-07-12 | 2001-12-18 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
-
2003
- 2003-11-03 GB GB0325598A patent/GB2407499B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB2407499A (en) | 2005-05-04 |
GB2407499B (en) | 2008-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL172316A0 (en) | Novel compounds and their use in therapy | |
IL174994A0 (en) | Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy | |
AU2003293376A8 (en) | Anti-angiogenic compounds and their use in cancer treatment | |
SG110107A1 (en) | Compound and use in treatment | |
GB0318546D0 (en) | Quinoxalinones and their use | |
GB0300804D0 (en) | Compounds and their use | |
GB0300805D0 (en) | Compounds and their use | |
GB0301143D0 (en) | Compounds and their use | |
GB0325598D0 (en) | Compound and use in treatment | |
GB0416876D0 (en) | Compound and use in treatment | |
GB0324205D0 (en) | Piperidinyl-diarylsilanol compounds and their use in threrapy | |
GB0317133D0 (en) | Compounds and their use | |
GB0325238D0 (en) | Composition and use | |
GB0301401D0 (en) | Composition and use | |
GB0311166D0 (en) | Composition and use | |
GB0311163D0 (en) | Composition and use | |
GB0311167D0 (en) | Composition and use | |
GB0325237D0 (en) | Composition and use | |
GB0325241D0 (en) | Composition and use | |
GB0311164D0 (en) | Composition and use | |
GB0325239D0 (en) | Composition and use | |
AU2003246880A8 (en) | Alkaloid-derived compounds and use thereof in cancer and malaria treatment | |
GB0306444D0 (en) | Composition and its therapeutic use | |
GB0309320D0 (en) | Compounds and their use | |
GB0302930D0 (en) | Compounds and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20091103 |